NorthWest Biotherapeutics Inc (NWBO)

[photonic5]

One of the things I remember learning about certain cancers was that there are master cells that initiate and sustain growth. I’m wondering if the reason that autologous tumor pulsed lysate DC doesn’t cure all patients is because 1. Some patients are immunocompromised and 2. In some patients, the whole tumor doesn’t contain all the antigens of the full range of master cells.

I truly believe that personalized immunotherapy is the future of cancer treatment, although I believe we are in the infancy of the technology. We sure could use that $54 million in outstanding warrant money to help develop it. NWBO is at the forefront of something special here...